Results(4683)
Real-world comparative effectiveness of tofacitinib, tumour necrosis factor inhibitors, and interleukin 17 inhibitors among patients with axial spondylarthritis and psoriatic arthritis
United States
EU PAS number:
EUPAS1000000226
First published:
25/06/2026
Study
Finalised
Describing Real-World Rimegepant Utilization Patterns and Understanding Perceptions of Migraine Treatment Optimization from the Perspectives of Patients
United States
EU PAS number:
EUPAS1000000232
First published:
25/06/2026
Study
Finalised
Impact of biologics on inhaled corticosteroids reduction (MOON LIGHT)
Argentina
Belgium
Brazil
Bulgaria
Canada
Colombia
Denmark
Estonia
France
Greece
India
Ireland
Italy
Japan
Korea, Republic of
Kuwait
Mexico
Norway
Poland
Portugal
Saudi Arabia
Singapore
Spain
Taiwan
United Arab Emirates
United Kingdom
United States
EU PAS number:
EUPAS1000000855
First published:
25/06/2026
Study
Finalised
Berlin Center for Epidemiology & Health Research, ZEG Berlin
Germany
First published:
23/06/2026
Institution
Laboratory/Research/Testing facility
ENCePP partner
Metamizole and Acute Kidney Injury (M-AKI)
Netherlands
EU PAS number:
EUPAS1000000740
First published:
23/06/2026
Study
Ongoing
A Post-Marketing Near Real-Time Safety Surveillance of Respiratory Syncytial Virus Vaccine for Guillain-Barre Syndrome (GBS) among Older Adults in the United States
United States
EU PAS number:
EUPAS1000000267
First published:
23/06/2026
Study
Finalised
Simultaneous Measurement of EpicArdial and Microvascular ResisTance via Angiographic FLOW Study (SMARTFLOW)
Belgium
France
United Kingdom
United States
EU PAS number:
EUPAS1000001032
First published:
23/06/2026
Study
Planned
Real-World Effects and Utilisation Patterns of Elexacaftor, Tezacaftor, and Ivacaftor Combination Therapy (ELX/TEZ/IVA) in Patients with Cystic Fibrosis (CF)
Germany
United States
EU PAS number:
EUPAS43022
First published:
23/06/2026
Study
Finalised
Functional Improvement and Safety of a Multicomponent Formulation Containing Undenatured UC-II® Collagen, Magnesium, Boswellia Serrata, and Turmeric in Patients with Joint Disorders (FISMFJD)
Spain
EU PAS number:
EUPAS1000001035
First published:
23/06/2026
Study
Finalised
Effectiveness and Safety of SMART BoNT-A therapy with Dysport® in patients with post-stroke chronic upper limb spasticity in real-life setting (SMART-NIS)
Germany
EU PAS number:
EUPAS107722
First published:
23/06/2026
Study
Finalised
DARWIN EU® - Treatment characterisation and post-diagnosis outcomes in Alzheimer’s disease
Croatia
Denmark
Germany
Netherlands
EU PAS number:
EUPAS1000000827
First published:
23/06/2026
Study
Finalised
Nivel Primary Care Database
Primary care medical records
Netherlands
First published:
22/06/2026
Data source
Human
Record completeness: 100%
VAC4EU Postauthorisation Effectiveness Study of BIMERVAX® Vaccine in Europe
Spain
EU PAS number:
EUPAS1000000337
First published:
22/06/2026
Study
Planned
VAC4EU Postauthorisation Safety Study of BIMERVAX® Vaccine in Europe
Spain
EU PAS number:
EUPAS1000000321
First published:
22/06/2026
Study
Planned
LOWER: Lomitapide Observational Worldwide Evaluation Registry (AEGR-733-025)
Canada
France
Greece
Italy
Netherlands
United Kingdom
United States
EU PAS number:
EUPAS5326
First published:
22/06/2026
Study
Ongoing
Vedolizumab-4081: Infection Outcomes among Advanced Therapy-naive Older Adult US Patients With UC/CD Initiating ENTYVIO, TNF-alpha Inhibitors, or Ustekinumab: A Retrospective Observational Matched-Cohort Study Using Medicare Claims Data, 2016-2025
United States
EU PAS number:
EUPAS1000000767
First published:
22/06/2026
Study
Planned
Observational Cohort Study of Safety of Etrasimod During Pregnancy in US Claims Databases (C5041042)
United States
EU PAS number:
EUPAS1000000832
First published:
19/06/2026
Study
Planned
A Post-Marketing Safety Study to Evaluate the Safety of VELSIPITY® (Etrasimod) Exposure During Pregnancy (C5041043)
Canada
United States
EU PAS number:
EUPAS1000000672
First published:
19/06/2026
Study
Ongoing
Observational study to assess effectiveness of ROTATEQ® against acute gastroenteritis (AGE) due to rotavirus (regardless of type) and by type in China
China
EU PAS number:
EUPAS1000000734
First published:
19/06/2026
Study
Finalised
Real-world experience of children with growth hormone deficiency who switched from daily growth hormone to the Long-Acting Growth Hormone Somatrogon
Czechia
Israel
EU PAS number:
EUPAS1000000829
First published:
19/06/2026
Study
Ongoing
Utilization and Effectiveness of PCSK9 Inhibitors in Familial Hypercholesterolemia
Canada
EU PAS number:
EUPAS1000000387
First published:
17/06/2026
Study
Finalised
Long-Acting Inhalable Drugs for Chronic Obstructive Pulmonary Disease
Canada
EU PAS number:
EUPAS1000000325
First published:
17/06/2026
Study
Finalised
Isotretinoin, Contraception, and Pregnancy Outcomes
Canada
EU PAS number:
EUPAS1000000927
First published:
17/06/2026
Study
Ongoing
Canadian Network for Observational Drug Effect Studies (CNODES)
Canada
First published:
17/06/2026
Network
Retrospective Cohort Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
United States
EU PAS number:
EUPAS45952
First published:
17/06/2026
Study
Ongoing
Clinical burden comparison among elderly hospitalized patients for COVID-19, RSV, and influenza: a French study on inpatients HER (OMIP Study)
France
EU PAS number:
EUPAS1000000275
First published:
17/06/2026
Study
Ongoing
Post-marketing Safety Study of mRNA-1283 in the United States
United States
EU PAS number:
EUPAS1000000971
First published:
16/06/2026
Study
Ongoing
Prospective Registry-Based Study Evaluating the Effectiveness and Safety of Odevixibat in Participants With Alagille Syndrome (ALGS)
United States
EU PAS number:
EUPAS1000000441
First published:
16/06/2026
Study
Ongoing
A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation – "BOSTON EVOLUTION"
Belgium
Spain
United States
EU PAS number:
EUPAS1000001016
First published:
16/06/2026
Study
Finalised
DARWIN EU® – Benzodiazepine use during pregnancy: a descriptive study characterising exposure, pregnancy loss, and covariates to inform future safety studies
Norway
Spain
EU PAS number:
EUPAS1000000536
First published:
15/06/2026
Study
Ongoing
Clinical Data Warehouse of the Bordeaux University Hospital
Other
France
First published:
12/06/2026
Data source
Human
Record completeness: 94%
Frequency of HIV diagnoses among people using oral and LA PrEP (223555)
United States
EU PAS number:
EUPAS1000000371
First published:
12/06/2026
Study
Ongoing
Belzutifan special drug use results survey in radically unresectable or metastatic renal cell carcinoma: a postauthorization safety study (PASS) (MK-6482-045)
Japan
EU PAS number:
EUPAS1000000880
First published:
12/06/2026
Study
Ongoing
Belzutifan special drug use results survey in von Hippel-Lindau (VHL) disease-associated tumors: a post-authorization safety study (PASS) (MK-6482-046)
Japan
EU PAS number:
EUPAS1000000881
First published:
12/06/2026
Study
Planned
Ustekinumab and Risk of Small for Gestational Age in Inflammatory Bowel Disease Pregnancies: Data from the DUMBO Registry
Spain
EU PAS number:
EUPAS1000001012
First published:
11/06/2026
Study
Finalised
Retrospective Multi-center Study of the Burden of MBL-producing Enterobacterales in Critically Ill Adults in Spain
Spain
EU PAS number:
EUPAS1000000733
First published:
11/06/2026
Study
Ongoing
DARWIN EU® - Azathioprine - user characteristics
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000322
First published:
11/06/2026
Study
Finalised
Effectiveness of LORlatinib as a Real-World, first-line treatment in ALK-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients in Italy(LOR-ALK).
Italy
EU PAS number:
EUPAS1000000856
First published:
10/06/2026
Study
Planned
A Post-Authorisation Safety Study to Evaluate the Safety of Marstacimab Among Patients with Haemophilia A or B using Real-World Data in Haemophilia Registers
United Kingdom
United States
EU PAS number:
EUPAS1000000947
First published:
10/06/2026
Study
Planned
Compare data sources
Compare data sources